Tetrahydrocannabinol (THC) Metabolite, Umbilical Cord Tissue, Qualitative
Also known as: THC QQQ CD
Use
This test is used to detect and document fetal exposure to THC during approximately the last trimester of a full-term pregnancy. It detects a common metabolite of THC, which may be present in cannabis products. It is specifically designed for medical purposes and is not valid for forensic use.
Special Instructions
Not provided.
Limitations
This test does not distinguish between the delta-8 and delta-9 forms of THC or their metabolites. The pattern and frequency of drug(s) used by the mother cannot be determined by this test. A negative result does not exclude the possibility that a mother used drugs during pregnancy. Detection depends on maternal drug use, drug stability, characteristics of drug deposition in umbilical cord tissue, and the analytical method's performance. Detection does not imply impairment and may not affect infant outcomes.
New York Approved
Methodology
Mass Spectrometry
Biomarkers
Carboxy-THC
Analyte
LOINC Codes
- 61063-4 - CarboxyTHC Spec Ql
Result Turnaround Time
1-3 days
Related Documents
For more information, please review the documents below
Specimen
Tissue (Unknown)
Volume
Not provided
Minimum Volume
6 inches
Container
Routine urine collection cup or Security Kit for Meconium/Umbilical Drug Detection
Collection Instructions
Drain and discard any blood. Rinse the exterior with normal saline or water, pat dry, and transport at least 8 inches of umbilical cord.
Storage Instructions
Refrigerated transport.
Causes for Rejection
Cords soaking in blood or other fluid, formalin fixed, or tissue that is obviously decomposed.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 1 week |
| Refrigerated | 3 weeks |
| Frozen | 1 year |
Other tests from different labs that may be relevant